FDA Updates Blood Donation Testing Requirements to Enhance Safety and Quality of Blood Supply

Summary

The Food and Drug Administration (FDA) is revising its standards for human blood and blood components to include new testing requirements for hepatitis C virus (HCV), human T-lymphotropic virus (HTLV), and to enhance the accuracy of existing tests for hepatitis B virus (HBV) and human immunodeficiency virus (HIV).